Tools & Calculators
Stocks
F&O
Mutual Funds
ITI Pharma and Healthcare Reg IDCW-R
as of 08 May 2026, 15:18 PM
Invested Amount
Est. Return
Total Value
rated by Value Research
Your principal will be at Very High Risk
Absolute Returns
CAGR
Company Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Healthcare | E | 11.80% |
| Divi's Laboratories Ltd | Healthcare | E | 8.77% |
| Apollo Hospitals Enterprise Ltd | Healthcare | E | 6.60% |
| Max Healthcare Institute Ltd Ordinary Shares | Healthcare | E | 5.50% |
| Torrent Pharmaceuticals Ltd | Healthcare | E | 5.28% |
| Aurobindo Pharma Ltd | Healthcare | E | 4.99% |
| Lupin Ltd | Healthcare | E | 4.20% |
| Laurus Labs Ltd | Healthcare | E | 3.65% |
| Alkem Laboratories Ltd | Healthcare | E | 3.12% |
| Fortis Healthcare Ltd | Healthcare | E | 2.91% |
| Neuland Laboratories Ltd | Healthcare | E | 2.66% |
| Aster DM Healthcare Ltd Ordinary Shares | Healthcare | E | 2.32% |
| Abbott India Ltd | Healthcare | E | 2.32% |
| Glenmark Pharmaceuticals Ltd | Healthcare | E | 2.15% |
| Cohance Lifesciences Ltd | Healthcare | E | 2.09% |
| Dr Reddy's Laboratories Ltd | Healthcare | E | 1.87% |
| Mankind Pharma Ltd | Healthcare | E | 1.85% |
| Sai Life Sciences Ltd | Healthcare | E | 1.82% |
| Ipca Laboratories Ltd | Healthcare | E | 1.70% |
| Cipla Ltd | Healthcare | E | 1.67% |
| Park Medi World Ltd | Healthcare | E | 1.49% |
| Linde India Ltd | Basic Materials | E | 1.39% |
| Biocon Ltd | Healthcare | E | 1.29% |
| SBI Life Insurance Co Ltd | Financial Services | E | 1.25% |
| HealthCare Global Enterprises Ltd | Healthcare | E | 1.24% |
| Sumitomo Chemical India Ltd Ordinary Shares | Basic Materials | E | 1.21% |
| FDC Ltd | Healthcare | E | 1.16% |
| OneSource Specialty Pharma Ltd | Healthcare | E | 1.15% |
| Rainbow Childrens Medicare Ltd | Healthcare | E | 1.11% |
| Shaily Engineering Plastics Ltd | Basic Materials | E | 1.11% |
| Piramal Pharma Ltd | Healthcare | E | 1.10% |
| Jubilant Ingrevia Ltd Ordinary Shares | Basic Materials | E | 1.06% |
| GlaxoSmithKline Pharmaceuticals Ltd | Healthcare | E | 1.00% |
| Orchid Pharma Ltd | Healthcare | E | 0.83% |
| Shilpa Medicare Ltd | Healthcare | E | 0.82% |
| Standard Engineering Technology Ltd | Industrials | E | 0.82% |
| Caplin Point Laboratories Ltd | Healthcare | E | 0.74% |
| Zydus Lifesciences Ltd | Healthcare | E | 0.69% |
| AstraZeneca Pharma India Ltd | Healthcare | E | 0.69% |
| Poly Medicure Ltd | Healthcare | E | 0.68% |
| Supriya Lifescience Ltd | Healthcare | E | 0.67% |
| Syngene International Ltd | Healthcare | E | 0.41% |
| Net Receivables / (Payables) | - | C | 0.80% |
Equity / Debt / Cash Split
Equity
99.2%
Cash
0.8%
Equity sector allocation
Basic Materials
4.77%
Financial Services
1.25%
Healthcare
92.36%
Industrials
0.82%
Others
0.8%
Asset Management Company

Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
32.27%
63.78%
3Y Returns
+63.78%

Mirae Asset NYSE FANG+ ETF FoF Reg Gr
Equity
Min. Investment
₹5000
Category Returns
32.27%
63.78%
3Y Returns
+48.34%

DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
32.27%
63.78%
3Y Returns
+45.98%
Investment Objective of the Scheme
Key Features of The Fund
5-year return
-
Fund Manager
Dhimant Shah
Risk Profile
Very High Risk
Expense Ratio
2.35%
Fund Size
₹211.30 Cr
The ITI Pharma and Healthcare Reg IDCW-R has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 11.80% |
| Divi's Laboratories Ltd | 8.77% |
| Apollo Hospitals Enterprise Ltd | 6.60% |
| Max Healthcare Institute Ltd Ordinary Shares | 5.50% |
| Torrent Pharmaceuticals Ltd | 5.28% |
| Aurobindo Pharma Ltd | 4.99% |
| Lupin Ltd | 4.20% |
| Laurus Labs Ltd | 3.65% |
| Alkem Laboratories Ltd | 3.12% |
| Fortis Healthcare Ltd | 2.91% |
| Neuland Laboratories Ltd | 2.66% |
| Aster DM Healthcare Ltd Ordinary Shares | 2.32% |
| Abbott India Ltd | 2.32% |
| Glenmark Pharmaceuticals Ltd | 2.15% |
| Cohance Lifesciences Ltd | 2.09% |
| Dr Reddy's Laboratories Ltd | 1.87% |
| Mankind Pharma Ltd | 1.85% |
| Sai Life Sciences Ltd | 1.82% |
| Ipca Laboratories Ltd | 1.70% |
| Cipla Ltd | 1.67% |
| Park Medi World Ltd | 1.49% |
| Linde India Ltd | 1.39% |
| Biocon Ltd | 1.29% |
| SBI Life Insurance Co Ltd | 1.25% |
| HealthCare Global Enterprises Ltd | 1.24% |
| Sumitomo Chemical India Ltd Ordinary Shares | 1.21% |
| FDC Ltd | 1.16% |
| OneSource Specialty Pharma Ltd | 1.15% |
| Rainbow Childrens Medicare Ltd | 1.11% |
| Shaily Engineering Plastics Ltd | 1.11% |
| Piramal Pharma Ltd | 1.10% |
| Jubilant Ingrevia Ltd Ordinary Shares | 1.06% |
| GlaxoSmithKline Pharmaceuticals Ltd | 1.00% |
| Orchid Pharma Ltd | 0.83% |
| Shilpa Medicare Ltd | 0.82% |
| Standard Engineering Technology Ltd | 0.82% |
| Caplin Point Laboratories Ltd | 0.74% |
| Zydus Lifesciences Ltd | 0.69% |
| AstraZeneca Pharma India Ltd | 0.69% |
| Poly Medicure Ltd | 0.68% |
| Supriya Lifescience Ltd | 0.67% |
| Syngene International Ltd | 0.41% |
| Net Receivables / (Payables) | 0.80% |
The ITI Pharma and Healthcare Reg IDCW-R has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | 4.77% |
| Communication Services | - |
| Consumer Cyclical | - |
| Consumer Defensive | - |
| Energy | - |
| Financial Services | 1.25% |
| Healthcare | 92.36% |
| Industrials | 0.82% |
| Real Estate | - |
| Technology | - |
| Utilities | - |
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in ITI Pharma and Healthcare Reg IDCW-R:
The exit load of ITI Pharma and Healthcare Reg IDCW-R is as follows:
Exit load of 0.5%, if redeemed within 1 year
.The following are the Steps to Redeem mutual funds on HDFC SKY:
1. Go to Mutual Funds > My Investments/Portfolio.
2. Select the fund and tap Redeem/Sell.
3. Choose Full, Units, or Amount.
4. Review NAV, units, and exit load.
5. Confirm. Amount (Units × NAV) is credited to the registered bank in T+1–T+3 days. ELSS has a 3-year lock-in.
By signing up I certify terms, conditions & privacy policy